Post-Kala-azar dermal leishmaniasis: A paradigm of paradoxical immune reconstitution syndrome in non-HIV/AIDS patients

Journal of Tropical Medicine

Volumn , Issue , 2013, Pages

  Khalil, Eltahir Awad Gasim ^a,b,c   Khidir, Selma Abdelmoneim ^a,b   Musa, Ahmed Mudawi ^a,b   Musa, Brema Younis ^a,b   Elfaki, Mona Elfaki Eltahir ^a,b   Elkadaru, Abdelgadir Mohamed Yousif ^a,d   Zijlstra, Edward ^a,b   El Hassan, Ahmed Mohamed ^a,b  

^a Leishmaniasis Research Group   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c MINISTRY OF SCIENCE AND TECHNOLOGY   (Sudan)

^d Tropical Diseases Hospital   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; LEISHMANIA VACCINE; PARASITE ANTIGEN; STIBOGLUCONATE SODIUM;

ALLERGIC REACTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; HUMAN; HUMAN CELL; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEISHMANIA DONOVANI; LEISHMANIN SKIN TEST; MACROPHAGE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; PARADOXICAL IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKIN INDURATION; SKIN LEISHMANIASIS;

EID: 84876577274     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2013/275253     Document Type: Article

References (64)

1. Zijlstra E. E., El Hassan A. M., Leishmaniasis in Sudan. Visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2001 95 S27 S58 2-s2.0-18044403852
2. Croft S. L., Sundar S., Fairlamb A. H., Drug resistance in leishmaniasis. Clinical Microbiology Reviews 2006 19 1 111 126 2-s2.0-31544439919 10.1128/CMR.19.1.111-126.2006 (Pubitemid 43157649)
3. Hailu A., Musa A., Wasunna M., Balasegaram M., Yifru S., Mengistu G., Hurissa Z., Hailu W., Weldegebreal T., Tesfaye S., Makonnen E., Khalil E., Ahmed O., Fadlalla A., El Hassan A., Raheem M., Mueller M., Koummuki Y., Rashid J., Mbui J., Mucee G., Njoroge S., Manduku V., Musibi A., Mutuma G., Kirui F., Lodenyo H., Mutea D., Kirigi G., Edwards T., Smith P., Muthami L., Royce C., Ellis S., Alobo M., Omollo R., Kesusu J., Owiti R., Kinuthia J., Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Neglected Tropical Diseases 2010 4 10, article e709 2-s2.0-78449231253 10.1371/journal.pntd.0000709
4. Sinha P. K., Roddy P., Palma P. P., Kociejowski A., Lima M. A., Das V. N. R., Gupta J., Kumar N., Mitra G., Saint-Sauveur J. F., Seena S., Balasegaram M., Parreño F., Pandey K., Effectiveness and safety of liposomal amphotericin b for visceral leishmaniasis under routine program conditions in Bihar, India. American Journal of Tropical Medicine and Hygiene 2010 83 2 357 364 2-s2.0-77955591768 10.4269/ajtmh.2010.10-0156
5. Desjeux P., Leishmania/HIV co-infections. Africa Health 1995 18 1 20 22 2-s2.0-0029402026
6. Mathur P., Samantaray J. C., Vajpayee M., Samanta P., Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics. Journal of Medical Microbiology 2006 55, part 7 919 922 2-s2.0-33745662611 10.1099/jmm.0.46574-0 (Pubitemid 43974699)
7. Ezra N., Ochoa M. T., Craft N., Human immunodeficiency virus and leishmaniasis. Journal of Global Infectious Diseases 2010 2 3 248 257
8. Hurissa Z., Gebre-Silassie S., Hailu W., Tefera T., Lalloo D. G., Cuevas L. E., Hailu A., Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia. Tropical Medicine and International Health 2010 15 7 848 855 2-s2.0-77953184307 10.1111/j.1365-3156.2010.02550.x
9. Zhou J., Sirisanthana T., Kiertiburanakul S., Chen Y. M. A., Han N., Lim P. L., Kumarasamy N., Choi J. Y., Merati T. P., Yunihastuti E., Oka S., Kamarulzaman A., Phanuphak P., Lee C. K. C., Li P. C. K., Pujari S., Saphonn V., Law M. G., Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infectious Diseases 2010 10, article 361 2-s2.0-78651492845 10.1186/1471-2334-10-361
10. Nascimento E. T., Moura M. L. N., Queiroz J. W., Barroso A. W., Araujo A. F., Rego E. F., Wilson M. E., Pearson R. D., Jeronimo S. M., The emergence of concurrent HIV-1/AIDS and visceral leishmaniasis in Northeast Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 2011 105 5 298 300 2-s2.0-79955018177 10.1016/j.trstmh.2011.01.006
11. Carvalho E. M., Teixeira R. S., Johnson W. D., Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infection and Immunity 1981 33 2 498 502 2-s2.0-0019442454 (Pubitemid 11042661)
12. Haldar J. P., Ghose S., Saha K. C., Ghose A. C., Cell-mediated immune response in Indian kala azar and post-kala azar dermal leishmaniasis. Infection and Immunity 1983 42 2 702 707 2-s2.0-0021075679 (Pubitemid 14230268)
13. Carvalho E. M., Badaro R., Reed S. G., Jones T. C., Johnson W. D., Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. Journal of Clinical Investigation 1985 76 6 2066 2069 2-s2.0-0022369062 (Pubitemid 16155495)
14. Weigle K. A., Valderrama L., Arias A. L., Santrich C., Saravia N. G., Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. American Journal of Tropical Medicine and Hygiene 1991 44 3 260 271 2-s2.0-0025736064
15. Zijlstra E. E., El Hassan A. M., Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar. Transactions of the Royal Society of Tropical Medicine and Hygiene 1993 87 4 425 427 2-s2.0-0027317998 10.1016/0035-9203(93)90024-K
16. Khalil E. A. G., El Hassan A. M., Zijlstra E. E., Mukhtar M. M., Ghalib H. W., Musa B., Ibrahim M. E., Kamil A. A., Elsheikh M., Babiker A., Modabber F., Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. The Lancet 2000 356 9241 1565 1569 2-s2.0-0034605714
17. Harith A. E., Kolk A. H. J., Kager P. A., Leeuwenburg J., Faber F. J., Muigai R., Kiugu S., Laarman J. J., Evaluation of a newly developed direct agglutination test (DAT) for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis: comparison with IFAT and ELISA. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987 81 4 603 606 2-s2.0-0023473931
18. Ghalib H. W., Piuvezam M. R., Skeiky Y. A. W., Siddig M., Hashim F. A., El Hassan A. M., Russo D. M., Reed S. G., Interleukin 10 production correlates with pathology in human Leishmania donovani infections. Journal of Clinical Investigation 1993 92 1 324 329 2-s2.0-0027323517 (Pubitemid 23209013)
19. Nylén S., Sacks D., Interleukin-10 and the pathogenesisof human visceral leishmaniasis. Trends in Immunology 2007 28 378 382 10.1016/j.it.2007.07.004 (Pubitemid 47385375)
20. Saha S., Mondal S., Ravindran R., Bhowmick S., Modak D., Mallick S., Rahman M., Kar S., Goswami R., Guha S. K., Pramanik N., Saha B., Ali N., IL-10- and TGF- β -mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. Journal of Immunology 2007 179 8 5592 5603 2-s2.0-38449097889
21. Ismail A., Immune responses and immunopathology of post kala-azar dermal Leishmaniasis [Ph.D. thesis] 1999 Copenhagen, Denmark University of Copenhagen
22. Zijlstra E. E., Musa A. M., Khalil E. A. G., El Hassan I. M., El Hassan A. M., Post-kala-azar dermal leishmaniasis. The Lancet Infectious Diseases 2003 3 2 87 98 2-s2.0-0037309309 10.1016/S1473-3099(03)00517-6 (Pubitemid 36164205)
23. Ismail A., Khalil E. A. G., Musa A. M., El Hassan I. M., Ibrahim M. E., Theander T. G., El Hassan A. M., The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role? Medical Hypotheses 2006 66 5 993 999 2-s2.0-32144446474 10.1016/j.mehy.2005.03.035 (Pubitemid 43207662)
24. Gasim S., El Hassan A. M., Khalil E. A. G., Ismail A., Kadaru A. M. Y., Kharazmi A., Theander T. G., High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clinical and Experimental Immunology 1998 111 64 69. Erratum in: Clinical and Experimental Immunology, vol. 112, pp. 574, 1998 (Pubitemid 28062778)
25. Gasim S., Theander T. G., El Hassan A. M., High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Acta Tropica 2000 75 1 35 38 2-s2.0-0033975572 10.1016/S0001-706X(99)00089-3 (Pubitemid 30089569)
26. Kamil A. A., Khalil E. A. G., Musa A. M., Modabber F., Mukhtar M. M., Ibrahim M. E., Zijlstra E. E., Sacks D., Smith P. G., Zicker F., El Hassan A. M., Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003 97 3 365 368 2-s2.0-4444327985 10.1016/S0035-9203(03)90171-4 (Pubitemid 39185899)
27. Musa A. M., Khalil E. A. G., Mahgoub F. A. E., Elgawi S. H. H., Modabber F., Elkadaru A. E. M. Y., Aboud M. H., Noazin S., Ghalib H. W., El Hassan A. M., Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 2008 102 1 58 63 2-s2.0-36549028707 10.1016/j.trstmh.2007.08.006 (Pubitemid 350177425)
28. El Hassan A. M., Khalil E. A. G., Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan? Tropical Medicine and International Health 2001 6 9 743 744 2-s2.0-0034851714 10.1046/j.1365-3156.2001.00776.x (Pubitemid 32823114)
29. Musa A. M., Khalil E. A. G., Raheem M. A., Zijlstra E. E., Ibrahim M. E., El Hassan I. M., Mukhtar M. M., El Hassan A. M., The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Annals of Tropical Medicine and Parasitology 2002 96 8 765 772 2-s2.0-0036976311 10.1179/000349802125002211 (Pubitemid 36152844)
30. Musa A. M., Khalil E. A. G., Mahgoub F. A., Elkadaru A. M. Y., El Hassan A. M., Hamad S., Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL). Annals of Tropical Medicine and Parasitology 2005 99 6 563 569 2-s2.0-24044546499 10.1179/136485905X514127 (Pubitemid 41215648)
31. Musa A. M., Khalil E. A. G., Ismail A., Safety, immunogenicity and possible efficacy of immunochemotherapy of persistent post kala-azar dermal leishmaniasis (PKDL). Sudanese Journal of Dermatology 2005 3 62 72
32. Shelburne S. A. III, Hamill R. J., Rodriguez-Barradas M. C., Greenberg S. B., Atmar R. L., Musher D. M., Gathe J. C., Visnegarwala F., Trautner B. W., Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002 81 3 213 227 2-s2.0-0036251741 10.1097/00005792-200205000-00005 (Pubitemid 34507208)
33. French M. A., Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Current HIV/AIDS Reports 2007 4 1 16 21 2-s2.0-34147095433 10.1007/s11904-007-0003-z (Pubitemid 46555247)
34. Bicanic T., Meintjes G., Rebe K., Williams A., Loyse A., Wood R., Hayes M., Jaffar S., Harrison T., Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. Journal of Acquired Immune Deficiency Syndromes 2009 51 2 130 134 2-s2.0-67649213979 10.1097/QAI.0b013e3181a56f2e
35. Elliott J. H., Vohith K., Saramony S., Savuth C., Dara C., Sarim C., Huffam S., Oelrichs R., Sophea P., Saphonn V., Kaldor J., Cooper D. A., Vun M. C., French M. A., Immunopathogenesis and diagnosis of tuberculosis and tuberculosis- associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. Journal of Infectious Diseases 2009 200 11 1736 1745 2-s2.0-72849121350 10.1086/644784
36. Elston J. W. T., Thaker H., Immune reconstitution inflammatory syndrome. International Journal of STD and AIDS 2009 20 4 221 224 2-s2.0-66349113882 10.1258/ijsa.2008.008449
37. French M. A., Immune reconstitution inflammatory syndrome: a reappraisal. Clinical Infectious Diseases 2009 48 1 101 107 2-s2.0-57749107807 10.1086/595006
38. van Tieu H., Ananworanich J., Avihingsanon A., Apateerapong W., Sirivichayakul S., Siangphoe U., Klongugkara S., Boonchokchai B., Hammer S. M., Manosuthi W., Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in thailand. AIDS Research and Human Retroviruses 2009 25 11 1083 1089 2-s2.0-71949109119 10.1089/aid.2009.0055
39. French M. A., Lenzo N., John M., Mallal S. A., McKinnon E. J., James I. R., Price P., Flexman J. P., Tay-Kearney M. L., Immune restoration disease after the treatment of imrrmnodeficient THIV-infected patients with highly active antiretroviral therapy. HIV Medicine 2000 1 2 107 115 2-s2.0-0034157717
40. Shelburne S. A., Montes M., Hamill R. J., Immune reconstitution inflammatory syndrome: more answers, more questions. Journal of Antimicrobial Chemotherapy 2006 57 2 167 170 2-s2.0-31544479585 10.1093/jac/dki444 (Pubitemid 43160154)
41. Amerson E. H., Maurer T. A., Immune reconstitution inflammatory syndrome and tropical dermatoses. Dermatologic Clinics 2011 29 1 39 43 2-s2.0-78649378051 10.1016/j.det.2010.09.007
42. Blanche P., Gombert B., Rivoal O., Abad S., Salmon D., Brezin A., Uveitis due to Leishmania major as part of HAART-induced immune restitution syndrome in a patient with AIDS. Clinical Infectious Diseases 2002 34 9 1279 1280 2-s2.0-0036570352 10.1086/338720 (Pubitemid 34450680)
43. Mutimer H. P., Akatsuka Y., Manley T., Chuang E. L., Boeckh M., Harrington R., Jones T., Riddell S. R., Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. Journal of Infectious Diseases 2002 186 5 701 705 2-s2.0-0036720944 10.1086/342044 (Pubitemid 34925544)
44. + lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathologica 2004 108 1 17 23 2-s2.0-3242688059 10.1007/s00401-004-0852-0 (Pubitemid 38961068)
45. Gray F., Bazille C., Adle-Biassette H., Mikol J., Moulignier A., Scaravilli F., Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. Journal of NeuroVirology 2005 11 supplement 3 16 22 2-s2.0-33645055683 10.1080/13550280500511741
46. Lortholary O., Fontanet A., Mémain N., Martin A., Sitbon K., Dromer F., Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005 19 10 1043 1049 2-s2.0-21844479866 (Pubitemid 40961144)
47. Phillips P., Bonner S., Gataric N., Bai T., Wilcox P., Kogg R., O'Shaughnessy M., Montaner J., Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term folow-up. Clinical Infectious Diseases 2005 41 10 1483 1497 2-s2.0-27644567236 10.1086/497269 (Pubitemid 41579994)
48. Breton G., Adle-Biassette H., Therby A., Ramanoelina J., Choudat L., Bissuel F., Huerre M., Dromer F., Dupont B., Lortholary O., Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 2006 20 1 119 121 2-s2.0-29144514807 (Pubitemid 41818123)
49. Batista M. D., Porro A. M., Maeda S. M., Gomes E. E., Yoshioka M. C. N., Enokihara M. M. S. S., Tomimori J., Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS. Clinical Infectious Diseases 2008 46 6 e56 e60 2-s2.0-40749147670 10.1086/528864 (Pubitemid 351417216)
50. Tan D. B. A., Yong Y. K., Tan H. Y., Kamarulzaman A., Tan L. H., Lim A., James I., French M., Price P., Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Medicine 2008 9 5 307 316 2-s2.0-42049094936 10.1111/j.1468-1293.2008.00565. x (Pubitemid 351517278)
51. Tamburini J., Grimaldi D., Chiche J. D., Bricaire F., Bossi P., Cytokine pattern in Kaposi's sarcoma associated with immune restoration disease in HIV and tuberculosis co-infected patients. AIDS 2007 21 14 1980 1983 2-s2.0-34548212838 10.1097/QAD.0b013e3282efa62c (Pubitemid 47329778)
52. Morlese J. F., Orkin C. M., Abbas R., Burton C., Qazi N. A., Nelson M. R., Imami N., Gazzard B. G., Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection. AIDS 2003 17 9 1411 1413 2-s2.0-0038336925 10.1097/00002030-200306130-00025 (Pubitemid 36819865)
53. + T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. European Journal of Immunology 2009 39 2 391 403 2-s2.0-60749107237 10.1002/eji.200838630
54. Sun H. Y., Singh N., Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Current Opinion in Infectious Diseases 2009 22 4 394 402 2-s2.0-67651154542 10.1097/QCO.0b013e32832d7aff
55. Worsley C. M., Suchard M. S., Stevens W. S., van Rie A., Murdoch D. M., Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS). AIDS Research and Therapy 2010 7, article 36 2-s2.0-77957365793 10.1186/1742-6405-7-36
56. Puthanakit T., Oberdorfer P., Punjaisee S., Wannarit P., Sirisanthana T., Sirisanthana V., Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection. Clinical Infectious Diseases 2005 41 7 1049 1052 2-s2.0-25444482091 10.1086/433177 (Pubitemid 41368232)
57. Matsuzaki G., Umemura M., Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiology and Immunology 2007 51 12 1139 1147 2-s2.0-37549030879
58. + T cell subsets contribute to the human anti-mycobacterial immune response. Journal of Immunology 2008 180 3 1962 1970 2-s2.0-40749159713
59. Tappuni A. R., Immune reconstitution inflammatory syndrome. Advances in Dental Research 2011 23 1 90 96 2-s2.0-79961048121 10.1177/0022034511399915
60. Lawn S. D., Bekker L. G., Miller R. F., Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. The Lancet Infectious Diseases 2005 5 6 361 373 2-s2.0-20344376921 10.1016/S1473-3099(05)70140-7 (Pubitemid 40779257)
61. + patients developing immune reconstitution inflammatory syndrome. Blood 2010 116 19 3818 3827 2-s2.0-77958616086 10.1182/blood-2010-05-285080
62. Tadesse A., Hurissa Z., Leishmaniasis (PKDL) as a case of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive patient after initiation of anti-retroviral therapy (ART). Ethiopian Medical Journal 2009 47 1 77 79 2-s2.0-70350501200
63. Antinori S., Longhi E., Bestetti G., Piolini R., Acquaviva V., Foschi A., Trovati S., Parravicini C., Corbellino M., Meroni L., Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome. British Journal of Dermatology 2007 157 5 1032 1036 2-s2.0-35348864585 10.1111/j.1365-2133.2007.08157.x (Pubitemid 47583507)
64. Khalil E. A. G., Ayed N. B., Musa A. M., Ibrahim M. E., Mukhtar M. M., Zijlstra E. E., El Hassan I. M., Smith P. G., Kieny P. M., Ghalib H. W., Zicker F., Modabber F., El Hassan A. M., Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clinical and Experimental Immunology 2005 140 2 349 353 2-s2.0-20244377212 10.1111/j.1365-2249.2005.02768.x (Pubitemid 40559163)